Categories
Weight Loss Products

Zithromax mg kg dose – What is azithromycin 250 mg taken for – Application of information technology in dental medicine

info@chicagomonitor.com

Categories
Weight Loss Products

Vical (VICL) Reaches $2.75 After 4.00% Up Move; NUTRAFUELS (NTFU) Shorts Decreased By 81.29%

<!–

Market News

–>

October 9, 2017 – By Winifred Garcia

The stock of Vical Incorporated (NASDAQ:VICL) is a huge mover today! About 481,352 shares traded or 46.79% up from the average. Vical Incorporated (NASDAQ:VICL) has declined 38.65% since October 9, 2016 and is downtrending. It has underperformed by 55.35% the SP500.The move comes after 7 months positive chart setup for the $31.36M company. It was reported on Oct, 9 by Barchart.com. We have $2.86 PT which if reached, will make NASDAQ:VICL worth $1.25 million more.

NUTRAFUELS (OTCMKTS:NTFU) had a decrease of 81.29% in short interest. NTFU’s SI was 6,400 shares in October as released by FINRA. Its down 81.29% from 34,200 shares previously. With 40,200 avg volume, 0 days are for NUTRAFUELS (OTCMKTS:NTFU)’s short sellers to cover NTFU’s short positions. About 23,600 shares traded. NutraFuels Inc (OTCMKTS:NTFU) has 0.00% since October 9, 2016 and is . It has underperformed by 16.70% the SP500.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products. The company has market cap of $16.45 million. The Company’s oral spray products are designed to provide more absorption than capsules or liquid formulas. It currently has negative earnings. The Company’s products include NutraFuels sleep spray; NutraFuels Energy Spray; NutraFuels Garcinia Cambogia Spray; NutraFuels Headache and Pain Spray, and NutraFuels Hair, Skin and Nails Spray.

Analysts await Vical Incorporated (NASDAQ:VICL) to report earnings on November, 2. They expect $-0.25 earnings per share, down 4.17% or $0.01 from last year’s $-0.24 per share. After $-0.30 actual earnings per share reported by Vical Incorporated for the previous quarter, Wall Street now forecasts -16.67% EPS growth.

Among 2 analysts covering Vical (NASDAQ:VICL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vical had 4 analyst reports since July 19, 2016 according to SRatingsIntel. The company was maintained on Wednesday, August 9 by H.C. Wainwright. The company was maintained on Monday, June 12 by H.C. Wainwright. H.C. Wainwright reinitiated the shares of VICL in report on Tuesday, July 19 with “Buy” rating. The stock has “Buy” rating by Rodman u0026 Renshaw on Monday, June 12.

Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.

Categories
Weight Loss Products

GNC Hit With $20M Suit Over Supplement Co.’s Collapse

Law360, New York (October 2, 2017, 4:30 PM EDT) — A $20 million acquisition of a dietary supplement maker fell apart because GNC Holdings Inc. underpaid it for products and broke an exclusivity deal, the company alleged in Arizona federal court on Friday.

Right Way Nutrition LLC alleged that GNC underpaid it about $1 million for a weight loss supplement and did not honor a one-year exclusivity agreement for a brain health product. Those actions by new GNC leadership helped tank the proposed $20 million sale of the supplement maker and destroyed its finances.

In 2013,…